EJE prize 2012: Obesity: From genes to behaviour

European Journal of Endocrinology

Volumn 171, Issue 5, 2014, Pages R191-R195

  Farooqi, I Sadaf ^a  

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LEPTIN; LEPTIN RECEPTOR; MELANOCORTIN; MELANOCORTIN 4 RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; RAF PROTEIN; RAS PROTEIN;

ARTICLE; CARDIOVASCULAR RISK; DISEASE SEVERITY; ENERGY BALANCE; ENERGY EXPENDITURE; FEEDING BEHAVIOR; FOOD INTAKE; GENE; GENETIC ASSOCIATION; HEREDITY; HORMONE ACTION; HUMAN; HYPOTHALAMUS; KSR2 GENE; LOSS OF FUNCTION MUTATION; MC4R GENE; METABOLIC REGULATION; OBESITY; ONSET AGE; PROTEIN FUNCTION; SEDENTARY LIFESTYLE; SIGNAL TRANSDUCTION; WEIGHT CONTROL; WEIGHT GAIN; ANIMAL; BEHAVIOR; BODY WEIGHT; ENVIRONMENT; GENETICS; NERVE TRACT; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGY;

ANIMALS; BEHAVIOR; BODY WEIGHT; ENVIRONMENT; GENES; HUMANS; HYPOTHALAMUS; NEURAL PATHWAYS; OBESITY;

EID: 84910132165     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-14-0684     Document Type: Article

References (22)

1. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L & Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994 372 425-432. (doi:10.1038/372425a0)
2. Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, Fei H, Kim S, Lallone R, Ranganathan S et al . Leptin levels in human and rodent:measurement of plasma leptin and ob RNA in obese and weightreduced subjects. Nature Medicine 1995 1 1155-1161. (doi:10.1038/ nm1195-1155)
3. Ahima RS, Prabakaran D, Mantzoros C, Qu D, Lowell B, Maratos-Flier E & Flier JS. Role of leptin in the neuroendocrine response to fasting. Nature 1996 382 250-252. (doi:10.1038/382250a0)
4. Elmquist JK, Bjorbaek C, Ahima RS, Flier JS & Saper CB. Distributions of leptin receptor mRNA isoforms in the rat brain. Journal of Comparative Neurology 1998 395 535-547. (doi:10.1002/(SICI)1096-9861(19980615)395:4<535::AID-CNE9>O3.0.CO;2-2)
5. Schwartz MW, Woods SC, Porte D Jr, Seeley RJ & Baskin DG. Central nervous system control of food intake. Nature 2000 404 661-671. (doi:10.1038/oby.2006.275)
6. Montague CT, Farooqi IS, Whitehead JP, Soos MA, Rau H,Wareham NJ, Sewter CP, Digby JE, Mohammed SN, Hurst JA et al. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 1997 387 903-908. (doi:10.1038/43185)
7. Farooqi IS, Jebb SA, Langmack G, Lawrence E, Cheetham CH, Prentice AM, Hughes IA, McCamish MA & O'Rahilly S. Effects of recombinant leptin therapy in a child with congenital leptin deficiency. New England Journal of Medicine 1999 341 879-884. (doi:10.1056/NEJM199909163411204)
8. Farooqi IS, Bullmore E, Keogh J, Gillard J, O'Rahilly S & Fletcher PC. Leptin regulates striatal regions and human eating behavior. Science 2007 317 1355. (doi:10.1126/science.1144599)
9. Clément K, Vaisse C, Lahlou N, Cabrol S, Pelloux V, Cassuto D, Gourmelen M, Dina C, Chambaz J & Lacorte JM. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction [see comments]. Nature 1998 392 398-401. (doi:10.1038/32911)
10. Farooqi IS, Wangensteen T, Collins S, Kimber W, Matarese G, Keogh JM, Lank E, Bottomley B, Lopez-Fernandez J, Ferraz-Amaro I et al. Clinical and molecular genetic spectrum of congenital deficiency of the leptin receptor. New England Journal of Medicine 2007 356 237-247. (doi:10.1056/NEJMoa063988)
11. Ozata M, Ozdemir IC & Licinio J. Human leptin deficiency caused by a missense mutation: multiple endocrine defects, decreased sympathetic tone, and immune system dysfunction indicate new targets for leptin action, greater central than peripheral resistance to the effects of leptin, and spontaneous correction of leptin-mediated defects. Journal of Clinical Endocrinology and Metabolism 1999 84 3686-3695. (doi:10.1210/ jcem.84.10.5999)
12. Farooqi IS, Matarese G, Lord GM, Keogh JM, Lawrence E, Agwu C, Sanna V, Jebb SA, Perna F, Fontana S et al. Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. Journal of Clinical Investigation 2002 110 1093-1103. (doi:10.1172/JCI0215693)
13. Galgani JE, Greenway FL, Caglayan S, Wong ML, Licinio J & Ravussin E. Leptin replacement prevents weight loss-induced metabolic adaptation in congenital leptin-deficient patients. Journal of Clinical Endocrinology and Metabolism 2010 95 851-855. (doi:10.1210/jc.2009-1739)
14. Coll AP, Farooqi IS, Challis BG, Yeo GS & O'Rahilly S. Proopiomelanocortin and energy balance: insights from human and murine genetics. Journal of Clinical Endocrinology and Metabolism 2004 89 2557-2562. (doi:10.1210/jc.2004-0428)
15. Huszar D, Lynch CA, Fairchild-Huntress V, Dunmore JH, Fang Q, Berkemeier LR, Gu W, Kesterson RA, Boston BA, Cone RD et al. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 1997 88 131-141. (doi:10.1016/S0092-8674(00)81865-6)
16. Vaisse C, Clement K, Durand E, Hercberg S, Guy-Grand B & Froguel P. Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity. Journal of Clinical Investigation 2000 106 253-262. (doi:10.1172/JCI9238)
17. Farooqi IS, Yeo GSH, Keogh JM, Aminian S, Jebb SA, Butler G, Cheetham T & O'Rahilly S. Dominant and recessive inheritance of morbid obesity associated with melanocortin 4 receptor deficiency. Journal of Clinical Investigation 2000 106 271-279. (doi:10.1172/JCI9397)
18. Farooqi IS. The severely obese patient - a genetic work-up. Nature Clinical Practice. Endocrinology & Metabolism 2006 2 172-177 quiz following 177. (doi:10.1038/ncpendmet0137)
19. Farooqi IS, Keogh JM, Yeo GS, Lank EJ, Cheetham T & O'Rahilly S. Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. New England Journal of Medicine 2003 348 1085-1095. (doi:10.1056/NEJMoa022050)
20. René P, Le Gouill C, Pogozheva ID, Lee G, Mosberg HI, Farooqi IS, Valenzano KJ & Bouvier M. Pharmacological chaperones restore function to MC4R mutants responsible for severe early-onset obesity. Journal of Pharmacology and Experimental Therapeutics 2010 335 520-532. (doi:10.1124/jpet.110.172098)
21. Greenfield JR, Miller JM, Keogh JW, Henning E, Satterwhite JH, Cameron GS, Astruc B, Mayer JP, Brage S, See TC et al . Modulation of blood pressure by central melanocortinergic pathways. New England Journal of Medicine 2009 360 44-52. (doi:10.1056/NEJMoa0803085)
22. Pearce LR, Atanassova N, Banton MC, Bottomley B, van der Klaauw AA, Revelli JP, Hendricks A, Keogh JM, Henning E, Doree D et al. KSR2 mutations are associated with obesity, insulin resistance, and impaired cellular fuel oxidation. Cell 2013 155 765-777. (doi:10.1016/j.cell.2013.09.058)